Every 10-Q that DOGECOIN CASH INC (DOGP) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow DOGP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DOGP filings page.
Dogecoin Cash, Inc. (symbol DOGP) reported continued losses for the quarter and six months ended June 30, 2026, while modestly improving operating performance. Q2 revenue was $166,511, down 13% from $192,464 a year earlier, reflecting sustained competitive pressure in the cannabis tele‑medicine industry. Net loss for Q2 was $137,706, versus $7.3 million in 2025, when results were heavily impacted by a large digital asset impairment.
For the first half of 2026, revenue was $359,409 (down 5%), with a net loss of $338,176. Operating expenses fell 29% in Q2, improving loss from continuing operations by 38%. Liquidity is strained: cash was $10,971 with operating cash outflow of $22,132 and an accumulated deficit of $84.7 million. Total liabilities of $2.49 million exceed assets, leaving a stockholders’ deficit of $320,711, and management states there is substantial doubt about the company’s ability to continue as a going concern without new capital, which would dilute shareholders. The company also discloses material weaknesses in internal controls and holds about 8.02 billion Dogecoin Cash tokens as indefinite‑lived digital assets.
Dogecoin Cash, Inc. reported Q1 2026 revenue of $192,898, up 5% from Q1 2025, with gross profit of $126,179 and a gross margin of 65%. Operating expenses rose 30% to $283,381, driven mainly by higher professional fees and general and administrative costs, leading to a net loss of $200,470 versus $107,364 a year earlier.
The balance sheet shows cash of $19,510, current liabilities of $870,246, and a stockholders’ deficit of $183,005, with an accumulated deficit of $84,587,856. Management states these factors raise substantial doubt about the company’s ability to continue as a going concern and indicates the need to raise additional capital, which could dilute existing shareholders.
The company holds approximately 8,020,000,000 Dogecoin Cash ($DOG) tokens recorded as indefinite-lived intangible assets and continues to focus operations on its PrestoDoctor cannabis telehealth platform. Management concludes disclosure controls and procedures were not effective due to material weaknesses tied to a small accounting staff, although no material legal proceedings are reported.
Dogecoin Cash, Inc. (DOGP) filed its Q3 2025 10‑Q reporting modest operating activity and significant losses. Revenue was $190,564 for the quarter, up 1% year over year, with gross margin at 64%. Quarterly loss from operations was $147,169, and net loss was $178,443.
For the nine months ended September 30, 2025, revenue was $567,501 (down 13%), reflecting increased competition in cannabis tele‑medicine. Total operating expenses fell 17% to $792,591, but the company recorded a $7,079,850 impairment tied to digital assets held by a subsidiary, driving a consolidated nine‑month net loss of $7,581,141. Cash used in operations was $36,658.
Liquidity remains tight: cash was $29,978 at quarter‑end, with an accumulated deficit of $84,305,776 and 160,109,031 common shares outstanding as of September 30, 2025. Management states the financial statements are prepared under a going concern basis and notes the need to raise capital, which would dilute current shareholders. Disclosure controls and procedures were deemed not effective due to material weaknesses stemming from a small accounting staff.